Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043669329> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W3043669329 endingPage "253" @default.
- W3043669329 startingPage "250" @default.
- W3043669329 abstract "Aim: To study the concentration of aqueous humor vascular endothelial growth factor (VEGF) before and after intravitreal injection of Bevacizumab in eyes with proliferative diabetic retinopathy (PDR) and correlate this with area of retinal ischemia and neovascularization.Methods: In this prospective, interventional case series; 1.25 mg of Bevacizumab was injected into the vitreous cavity in 48 PDR eyes of 29 consecutive patients. Aqueous humor samples were obtained before intravitreal Bevacizumab injection and 1 week after, or before starting cataract surgery in the controls. The controls were 15 consecutive non-diabetic patients undergoing cataract surgery (15 eyes).Results: Aqueous VEGF level was higher in eyes with PDR than in control eyes (474.2 ± 361.3 vs. 120.65 ± 45.05 pg/mL) and this level reduced to 16.96 ± 18.1 pg/ mL 1 week after Bevacizumab injection (p<0.001). There was significant correlation between aqueous VEGF level and retinal ischemia-neovascularization area. No correlation between aqueous VEGF level and clinical markers such as blood glucose levels, HbA1C lever and duration of diabetes.Conclusion: VEGF levels correlate with the area of retinal ischemia and presence of neovascularization." @default.
- W3043669329 created "2020-07-23" @default.
- W3043669329 creator A5003137292 @default.
- W3043669329 creator A5004904994 @default.
- W3043669329 creator A5006298933 @default.
- W3043669329 creator A5007646632 @default.
- W3043669329 creator A5028972459 @default.
- W3043669329 creator A5039478629 @default.
- W3043669329 creator A5058933768 @default.
- W3043669329 creator A5065585014 @default.
- W3043669329 date "2020-01-01" @default.
- W3043669329 modified "2023-09-22" @default.
- W3043669329 title "Aqueous humor vascular endothelial growth factor concentration before and after intravitreal injection of Bevacizumab for diabetic retinopathy" @default.
- W3043669329 hasPublicationYear "2020" @default.
- W3043669329 type Work @default.
- W3043669329 sameAs 3043669329 @default.
- W3043669329 citedByCount "0" @default.
- W3043669329 crossrefType "journal-article" @default.
- W3043669329 hasAuthorship W3043669329A5003137292 @default.
- W3043669329 hasAuthorship W3043669329A5004904994 @default.
- W3043669329 hasAuthorship W3043669329A5006298933 @default.
- W3043669329 hasAuthorship W3043669329A5007646632 @default.
- W3043669329 hasAuthorship W3043669329A5028972459 @default.
- W3043669329 hasAuthorship W3043669329A5039478629 @default.
- W3043669329 hasAuthorship W3043669329A5058933768 @default.
- W3043669329 hasAuthorship W3043669329A5065585014 @default.
- W3043669329 hasConcept C118487528 @default.
- W3043669329 hasConcept C126322002 @default.
- W3043669329 hasConcept C134018914 @default.
- W3043669329 hasConcept C141071460 @default.
- W3043669329 hasConcept C167734588 @default.
- W3043669329 hasConcept C2775888743 @default.
- W3043669329 hasConcept C2776694085 @default.
- W3043669329 hasConcept C2777025900 @default.
- W3043669329 hasConcept C2777802072 @default.
- W3043669329 hasConcept C2778271429 @default.
- W3043669329 hasConcept C2779829184 @default.
- W3043669329 hasConcept C2780394083 @default.
- W3043669329 hasConcept C2780827179 @default.
- W3043669329 hasConcept C2993390227 @default.
- W3043669329 hasConcept C541997718 @default.
- W3043669329 hasConcept C555293320 @default.
- W3043669329 hasConcept C71924100 @default.
- W3043669329 hasConceptScore W3043669329C118487528 @default.
- W3043669329 hasConceptScore W3043669329C126322002 @default.
- W3043669329 hasConceptScore W3043669329C134018914 @default.
- W3043669329 hasConceptScore W3043669329C141071460 @default.
- W3043669329 hasConceptScore W3043669329C167734588 @default.
- W3043669329 hasConceptScore W3043669329C2775888743 @default.
- W3043669329 hasConceptScore W3043669329C2776694085 @default.
- W3043669329 hasConceptScore W3043669329C2777025900 @default.
- W3043669329 hasConceptScore W3043669329C2777802072 @default.
- W3043669329 hasConceptScore W3043669329C2778271429 @default.
- W3043669329 hasConceptScore W3043669329C2779829184 @default.
- W3043669329 hasConceptScore W3043669329C2780394083 @default.
- W3043669329 hasConceptScore W3043669329C2780827179 @default.
- W3043669329 hasConceptScore W3043669329C2993390227 @default.
- W3043669329 hasConceptScore W3043669329C541997718 @default.
- W3043669329 hasConceptScore W3043669329C555293320 @default.
- W3043669329 hasConceptScore W3043669329C71924100 @default.
- W3043669329 hasIssue "2" @default.
- W3043669329 hasLocation W30436693291 @default.
- W3043669329 hasOpenAccess W3043669329 @default.
- W3043669329 hasPrimaryLocation W30436693291 @default.
- W3043669329 hasRelatedWork W1969169427 @default.
- W3043669329 hasRelatedWork W1970554379 @default.
- W3043669329 hasRelatedWork W1980739597 @default.
- W3043669329 hasRelatedWork W2007155254 @default.
- W3043669329 hasRelatedWork W2089400517 @default.
- W3043669329 hasRelatedWork W2094521208 @default.
- W3043669329 hasRelatedWork W2104360273 @default.
- W3043669329 hasRelatedWork W2163635822 @default.
- W3043669329 hasRelatedWork W2352224401 @default.
- W3043669329 hasRelatedWork W2395547700 @default.
- W3043669329 hasRelatedWork W2415034759 @default.
- W3043669329 hasRelatedWork W2614668598 @default.
- W3043669329 hasRelatedWork W2955403147 @default.
- W3043669329 hasRelatedWork W2994346052 @default.
- W3043669329 hasRelatedWork W3030468177 @default.
- W3043669329 hasRelatedWork W3145398775 @default.
- W3043669329 hasRelatedWork W3199410633 @default.
- W3043669329 hasRelatedWork W589204626 @default.
- W3043669329 hasRelatedWork W792968164 @default.
- W3043669329 hasRelatedWork W869655158 @default.
- W3043669329 hasVolume "4" @default.
- W3043669329 isParatext "false" @default.
- W3043669329 isRetracted "false" @default.
- W3043669329 magId "3043669329" @default.
- W3043669329 workType "article" @default.